What is CUSIP 91324P102?

CUSIP 91324P102 is the security identifier used in SEC filing datasets for UNH - UNITEDHEALTH GROUP INC - Common Stock.

Who owns UNH - UNITEDHEALTH GROUP INC - Common Stock based on 13F filings?

3007 institutions reported positions in UNH - UNITEDHEALTH GROUP INC - Common Stock as of Q1 2026. Open the latest holders period and ownership history tables on this page for position-level details.

Security Snapshot

UNITEDHEALTH GROUP INC - Common Stock (UNH) Institutional Ownership

CUSIP: 91324P102

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

3,007

Shares (Excl. Options)

746,550,485

Price

$270.59

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / Common Stock
Symbol: UNH on NYSE
All holders as of 31 Mar 2026: Q1 2026
Total 13F shares: 746,550,485
Total 13F value: $202,200,856,296
Portfolio coverage rank: 0.12%
Share change: -4,478,409
Value change: -$2,952,776,019
Number of holders: 3,007
Shares outstanding: 908,299,773
SEC-reported price per share: $388.47
Insider filing price: $388.47

13F Shares, Excluding Options vs Price

13F Value, Excluding Options

Total Investors

Key facts

UNH - UNITEDHEALTH GROUP INC - Common Stock is tracked under CUSIP 91324P102.
3007 institutions reported positions in Q1 2026.
1 significant owner is listed from Schedule 13D/13G reporting.

Change

Holder count moved from 3,277 to 3,007 between Q4 2025 and Q1 2026.
SEC-reported value moved from $247,525,433,148 to $202,200,856,296.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 3007 institutions filings for Q1 2026.

Open SEC evidence

Security key

91324P102

Latest holder period

Q1 2026

13F holders

3,007

13D/G owners

CIK / CUSIP context first

Open Q1 2026 holders UNH full holder history UNITEDHEALTH GROUP INC SEC filings UNITEDHEALTH GROUP INC company facts UNITEDHEALTH GROUP INC insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 91324P102:

Q1 2026 (3007 holders) Q4 2025 (3277 holders) Q3 2025 (3138 holders) Q2 2025 (3131 holders) Q1 2025 (3567 holders) Q4 2024 (3642 holders) Q3 2024 (3438 holders) Q2 2024 (3373 holders) Q1 2024 (3353 holders) Q4 2023 (3398 holders)

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows

Security

UNH

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
VANGUARD CAPITAL MANAGEMENT LLC	7.5%		$18,433,262,675		68,122,483		Vanguard Capital Management	31 Mar 2026

As of 31 Mar 2026, 3,007 institutional investors reported holding 746,550,485 shares of UNITEDHEALTH GROUP INC - Common Stock (UNH). This represents 82% of the company’s total 908,299,773 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share

51%

Institution	Ownership %	Shares Held	Share Change %	Portfolio %	Holdings Value
BlackRock, Inc.	8.1%	73,467,531	-1.7%	0.35%	$19,879,579,128
VANGUARD CAPITAL MANAGEMENT LLC	6.5%	58,870,777	0%	0.39%	$15,929,843,548
STATE STREET CORP	5%	45,332,186	+0.22%	0.42%	$12,266,436,210
Capital World Investors	3.1%	27,783,415	+23%	1%	$7,517,089,294
VANGUARD PORTFOLIO MANAGEMENT LLC	2.6%	24,036,504	0%	0.34%	$6,504,037,617
GEODE CAPITAL MANAGEMENT, LLC	2.5%	22,768,695	+4.5%	0.38%	$6,140,006,802
PRICE T ROWE ASSOCIATES INC /MD/	2.3%	20,873,946	+11%	0.65%	$5,648,283,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	2.3%	20,817,755	+147%	0.86%	$5,633,029,995
JPMORGAN CHASE & CO	2.1%	19,102,541	+11%	0.34%	$5,000,854,880
Capital Research Global Investors	1.9%	17,112,218	+173%	0.72%	$4,629,794,298
MORGAN STANLEY	1.6%	14,963,569	-5.2%	0.24%	$4,048,992,970
FMR LLC	1.3%	12,019,046	-5.4%	0.17%	$3,252,233,704
BANK OF AMERICA CORP /DE/	1.3%	11,713,684	+22%	0.23%	$3,169,605,772
WELLINGTON MANAGEMENT GROUP LLP	1.1%	10,091,639	-36%	0.51%	$2,730,696,597
Bank of New York Mellon Corp	1.1%	10,088,271	+10%	0.5%	$2,729,785,250
Dodge & Cox	1%	9,466,756	+3.2%	1.4%	$2,561,609,506
Capital International Investors	0.99%	9,001,312	-52%	0.57%	$2,434,371,252
NORTHERN TRUST CORP	0.97%	8,779,907	-0.76%	0.31%	$2,375,755,035
GOLDMAN SACHS GROUP INC	0.86%	7,837,182	+27%	0.28%	$2,120,663,325
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	0.82%	7,442,890	+2.6%	0.42%	$2,013,971,605
ALLIANCEBERNSTEIN L.P.	0.71%	6,443,863	-4.1%	0.7%	$2,127,183,615
Amundi	0.7%	6,376,198	-13%	0.47%	$1,725,333,883
Invesco Ltd.	0.7%	6,316,462	+19%	0.26%	$1,709,171,287
Legal & General Group Plc	0.67%	6,119,044	+0.99%	0.38%	$1,655,752,116
Sanders Capital, LLC	0.66%	5,964,685	-0.54%	1.9%	$1,613,984,114

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods

Latest

Q1 2026

Rows shown

1-25 of 49

Period	13F Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2026 Q1	746,550,485	$202,200,856,296	-$2,952,776,019	$11,721,833,713	$12,307,408,281	$270.59	3,007
2025 Q4	749,905,774	$247,525,433,148	+$4,665,197,422	$13,832,231,989	$16,438,376,192	$330.11	3,277
2025 Q3	733,201,628	$253,192,258,104	-$12,711,237,446	$16,943,108,330	$20,070,567,206	$345.30	3,138
2025 Q2	771,542,028	$240,595,782,361	-$10,571,955,245	$10,296,092,878	$12,447,984,990	$311.97	3,131
2025 Q1	797,598,075	$417,643,400,722	-$5,449,198,502	$4,082,832,181	$4,982,250,230	$523.75	3,567
2024 Q4	806,973,684	$408,449,626,515	-$2,857,547,861	$4,394,119,665	$4,473,358,144	$505.86	3,642
2024 Q3	808,399,065	$472,751,670,791	+$536,968,408	$4,080,923,039	$3,921,055,916	$584.68	3,438
2024 Q2	807,195,884	$410,870,744,205	+$3,698,568,008	$2,846,569,653	$2,939,512,073	$509.26	3,373
2024 Q1	804,409,692	$397,895,565,873	-$3,596,367,294	$3,319,563,125	$2,975,536,946	$494.70	3,353
2023 Q4	811,684,815	$427,337,906,406	+$1,269,099,237	$3,540,680,212	$3,442,211,372	$526.47	3,398
2023 Q3	807,047,993	$407,064,409,089	+$29,840,695	$3,175,465,675	$3,461,837,169	$504.19	3,124
2023 Q2	807,436,870	$388,009,732,260	-$2,012,490,472	$2,974,386,317	$3,005,195,160	$480.64	3,114
2023 Q1	808,474,510	$382,197,287,112	-$4,024,513,372	$2,228,557,837	$3,156,697,114	$472.59	3,088
2022 Q4	820,780,873	$434,962,144,637	+$1,640,479,205	$3,298,109,036	$3,664,197,588	$530.18	3,132
2022 Q3	819,110,695	$413,921,310,921	-$2,861,075,687	$3,014,296,632	$3,184,136,456	$505.04	2,979
2022 Q2	820,943,270	$421,685,534,400	+$3,837,211,427	$2,442,889,566	$2,418,503,704	$513.63	2,942
2022 Q1	819,430,583	$418,020,136,225	-$1,922,096,975	$2,272,354,443	$2,311,740,971	$509.97	2,945
2021 Q4	822,461,953	$412,886,970,243	+$338,188,515	$3,551,151,576	$3,035,284,118	$502.14	2,881
2021 Q3	821,230,329	$321,038,610,215	-$552,649,201	$2,778,682,304	$2,093,412,340	$390.74	2,551
2021 Q2	822,505,331	$329,392,618,180	-$386,283,681	$2,338,499,372	$1,839,349,656	$400.44	2,572
2021 Q1	824,687,305	$306,832,275,208	-$977,228,421	$1,837,259,800	$1,760,907,000	$372.07	2,499
2020 Q4	827,090,816	$289,956,485,062	-$466,235,188	$2,275,775,568	$1,846,599,700	$350.68	2,452
2020 Q3	828,412,014	$258,095,751,488	-$1,380,200,918	$2,309,394,000	$1,927,085,000	$311.77	2,225
2020 Q2	831,401,889	$245,173,503,951	+$946,598,999	$2,054,957,740	$1,833,095,175	$294.95	2,198
2020 Q1	828,591,495	$206,700,628,181	-$902,851,686	$1,792,789,000	$1,559,731,000	$249.38	2,111